954 — Changmao Biochemical Engineering Co Income Statement
0.000.00%
Last trade - 00:00
- HK$201.29m
- HK$529.74m
- CNY730.03m
2018 December 31st | 2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 639 | 495 | 444 | 548 | 730 |
Cost of Revenue | |||||
Gross Profit | 130 | 135 | 95.4 | 38.7 | 181 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 584 | 432 | 427 | 462 | 641 |
Operating Profit | 55.5 | 62.8 | 17 | 85.8 | 89.4 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 54.6 | 62.6 | 17.2 | 84.4 | 87.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 49.9 | 57.9 | 16.7 | 58.2 | 81.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 50.5 | 58.3 | 16.8 | 58.3 | 81.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 50.5 | 58.3 | 16.8 | 58.3 | 81.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.098 | 0.113 | 0.058 | -0.007 | 0.177 |
Dividends per Share |